VITRUVIAS THERAPEUTICS INC recalls Thyroid Tablets
- Published
- 23 Sept 2026
- Units affected
- 1955 bottles
- Agency
- FDA
- Country
- United States
The hazard
Superpotent Drug
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
- Brand / company
- VITRUVIAS THERAPEUTICS INC
- Codes / lots
- Lot # 504950, Exp Date: 09/30/2026.
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 23 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.